Manufacturers receiving FDA orders to
track a device, whose failure would likely have serious adverse
health consequences, and which is implanted in humans for more than
1 year, or is life-sustaining or life-supporting and used outside a
device user facility, are required to collect/maintain current
tracking information about the identity and location of the device
during distribution, and about the identity and location of
patients receiving the device, including certain physician
information. Distributors must report this data to
manufacturers.
The burden hours and responses
have been adjusted as the result of re-estimating and re-evaluating
submissions and tracking data by the agency. FDA attributes the
reduction to the decreased number of tracking orders issued since
original estimates were provided. More specifically, while the Safe
Medical Devices Act of 1990 required tracking by all manufacturers
of certain devices, FDAMA (enacted in 1997) provides that devices
subject to tracking would be determined at the Agency's discretion
and only upon order by FDA.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.